EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel methylation signature predicts extreme long-term survival in glioblastoma

Brecht Decraene, Grégoire Coppens, Lien Spans, Lien Solie, Raf Sciot, Isabelle Vanden Bempt, Frederik De Smet, Steven De Vleeschouwer

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04741-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Brecht Decraene und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Experimental Neurosurgery and Neuroanatomy Research Group, Leuven Brain Institute (LBI), KU Leuven, Leuven, Belgium. bre…. Hauptthemen laut MEDLINE: Glioblastoma, DNA Methylation, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Glioblastoma (GBM) is the most common malignant primary brain tumor with a dismal prognosis of less than 2 years under maximal therapy. Despite the poor prognosis, small fractions of GBM patients seem to have a markedly longer survival than the vast majority of patients. Recently discovered intertumoral heterogeneity is thought to be responsible for this peculiarity, although the exact underlying mechanisms remain largely unknown. Here, we investigated the epigenetic contribution to survival.

Methods

GBM treatment-naïve samples from 53 patients, consisting of 12 extremely long-term survivors (eLTS) patients and 41 median-term survivors (MTS) patients, were collected for DNA methylation analysis. 865 859 CpG sites were examined and processed for detection of differentially methylated CpG positions (DMP) and regions (DMR) between both survival groups. Gene Ontology (GO) and pathway functional annotations were used to identify associated biological processes. Verification of these findings was done using The Cancer Genome Atlas (TCGA) database.

Results

We identified 67 DMPs and 5 DMRs that were associated with genes and pathways - namely reduced interferon beta signaling, in MAPK signaling and in NTRK signaling - which play a role in survival in GBM.

Conclusion

In conclusion, baseline DNA methylation differences already present in treatment-naïve GBM samples are part of genes and pathways that play a role in the survival of these tumor types and therefore may explain part of the intrinsic heterogeneity that determines prognosis in GBM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaDNA MethylationBrain NeoplasmsHumansMaleFemaleMiddle AgedPrognosisAgedAdultCpG IslandsGene Expression Regulation, NeoplasticBiomarkers, TumorEpigenesis, GeneticSurvival Rate

Stichwörter der Autor:innen

DNA-methylationEpigeneticsGlioblastomaLong-term survival

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosciences, Experimental Neurosurgery and Neuroanatomy Research Group, Leuven Brain Institute (LBI), KU Leuven, Leuven, Belgium. brecht.decraene@kuleuven.be.
  • Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium. brecht.decraene@kuleuven.be.
  • Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, KU Leuven, Leuven, Belgium. brecht.decraene@kuleuven.be.
  • The Leuven Institute for Single-Cell Omics (LISCO), KU Leuven, Leuven, Belgium. brecht.decraene@kuleuven.be.
  • Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Department of Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Zitieren

APA

Decraene, B., Coppens, G., Spans, L., Solie, L., Sciot, R., Vanden Bempt, I., De Smet, F., & De Vleeschouwer, S. (2024). A novel methylation signature predicts extreme long-term survival in glioblastoma. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04741-z

Vancouver

Decraene B, Coppens G, Spans L, Solie L, Sciot R, Vanden Bempt I, et al. A novel methylation signature predicts extreme long-term survival in glioblastoma. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04741-z

BibTeX
@article{Decraene2024,
  author = {Decraene, Brecht and Coppens, Grégoire and Spans, Lien and Solie, Lien and Sciot, Raf and Vanden Bempt, Isabelle and De Smet, Frederik and De Vleeschouwer, Steven},
  title = {A novel methylation signature predicts extreme long-term survival in glioblastoma},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04741-z}
}
Kostenlos starten →